English
There is a desperate need to regenerate tissues particularly to alleviate the burden of age related chronic diseases, including osteoarthritis (OA). Within this field of regenerative medicine, human iPS-cell technology is anticipated a game changer; iPS-cells differentiate on demand to any cell-type hence facilitating development of effective curative regenerative therapies for a broad area of clinical applications. Despite this fascinating promise, the lack of insight, hence a solution, to the uncontrollable, heterogeneous iPS-cell differentiation currently prevents application of this powerful technology towards regenerative solutions in the clinical setting. With the overall aim to advance the use of iPS-cells towards clinical applications in joint diseases and beyond SCI-MAP is designed to determine and understand key modifiable factors that direct and maintain iPS-cell differentiation into stable chondrogenic lineages. Specifically, our strategy is to reliably capture temporal factors that determine cell fate decisions towards the chondrogenic lineages at the single cell level by: - Applying microfluidic droplet technology to produce 3D, mechanically tunable, micro-meter-thin hydrogels containing a single iPS-cell. This strategy will facilitate differentiation of single iPS-cells into the chondrogenic lineage in a biomimetic microenvironment. - Generating a reliable blueprint of iPS-cell differentiation towards the chondrogenic lineage at 4 time points by applying simultaneous RNA-, ATAC-, and bisulphite-sequencing at the single cell level. Integration of different levels of molecular information will allow for characterization of dynamic changes in the epigenetically regulated transcriptome while discerning the region/genes that actively regulate, direct and maintain chondroprogenitor cell fate. All at the single cell level. - Implementing a systems biology approach to generate dynamic in silico iPS-cell models describing differentiation towards the chondrogenic lineage. These models are dynamic and interactive and can be exploited for ‘what if’ scenarios hence predicting modifiable factors that direct cell fate decisions. Overall, our project is fuelled by the multi-disciplinary nature of our team, and the conviction that unprecedented integration of technologies and expertise is essential to cross critical barriers and advance the field of regenerative medicine for joint diseases. This, to eventually alleviate the enormous social and economic burden that joint disease put on modern society.
